A phase 1b multicenter double-blind, placebo-controlled, randomized study on the safety and tolerability of Z-100 in early HIV-1 infected patients
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Z 100 (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 22 Jan 2008 Status change
- 21 Aug 2006 Status change
- 18 Oct 2005 New trial record.